Women’s-health, Fosamax (Alendronate)
Alendronate is accepted for the treatment of osteoporosis (thinning of bone) in women after menopause. After menopause, it is observed an increased rate of bone loss (resorption). In these patients, alendronate extends bone density by strengthening bone, and reduses the rate of bone fractures. Alendronate can also help during the treatment of Paget’s disease of the bone. This disease consists from a disorderly and accelerated bone’s remodelation which leads to bone weakness and pain. DOSING: For the best absorption alendronate should be taken at least 30 minutes before food, beverage, vitamins or medicines. Alendronate should be accepted with a full glass of plain water first thing in the morning. It is necessary for prevention of chemical irritation of the esophagus (the tube that connects the mouth with the stomach). You shouldn’t chew or suck the tablet. In case of having abnormalities of the esophagus which delay esophageal emptying, such as scarring (stricture) or poor motility (achalasia) patients shouldn’t accept this drug. Patients shouldn’t lie down for 30 minutes after swallowing the tablets if it is impossible this drug should be avoided